Silibinins and curcumin as promising ligands against mutant cystic fibrosis transmembrane regulator protein
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Silibinins and curcumin as promising ligands against mutant cystic fibrosis transmembrane regulator protein ; volume:14 ; number:1 ; day:23 ; month:7 ; year:2024 ; pages:1-18 ; date:12.2024
AMB express ; 14, Heft 1 (23.7.2024), 1-18, 12.2024
- Urheber
-
Akram, Areeba
Sakhawat, Azra
Ghani, Muhammad Usman
Khan, Muhammad Umer
Rehman, Raima
Ali, Qurban
Jin-liang, Peng
Ali, Daoud
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13568-024-01742-z
- URN
-
urn:nbn:de:101:1-2410090814430.828889867038
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Akram, Areeba
- Sakhawat, Azra
- Ghani, Muhammad Usman
- Khan, Muhammad Umer
- Rehman, Raima
- Ali, Qurban
- Jin-liang, Peng
- Ali, Daoud
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
Glycosylation and the cystic fibrosis transmembrane conductance regulator
The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
Sphingosine-1-Phosphate is a novel regulator of cystic fibrosis transmembrane conductance regulator (CFTR) activity
'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease
Auswirkungen von Mutationen auf die Funktion von CFTR (Cystic fibrosis transmembrane conductance regulator)
Molecular dynamics study of Cl− permeation through cystic fibrosis transmembrane conductance regulator (CFTR)
Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulator
Charakterisierung der Interaktionen des CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) mit PDZ-Domänen-Proteinen
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
Glycosylation and the cystic fibrosis transmembrane conductance regulator
The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
Sphingosine-1-Phosphate is a novel regulator of cystic fibrosis transmembrane conductance regulator (CFTR) activity
'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease
Auswirkungen von Mutationen auf die Funktion von CFTR (Cystic fibrosis transmembrane conductance regulator)
Molecular dynamics study of Cl− permeation through cystic fibrosis transmembrane conductance regulator (CFTR)
Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulator
Charakterisierung der Interaktionen des CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) mit PDZ-Domänen-Proteinen
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
Glycosylation and the cystic fibrosis transmembrane conductance regulator
The cystic fibrosis transmembrane conductance regulator (CFTR) and its stability
Cystic fibrosis transmembrane regulator correction attenuates heart failure-induced lung inflammation
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators have differential effects on cystic fibrosis macrophage function
Sphingosine-1-Phosphate is a novel regulator of cystic fibrosis transmembrane conductance regulator (CFTR) activity
'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
A pathogenic role for cystic fibrosis transmembrane conductance regulator in celiac disease
Auswirkungen von Mutationen auf die Funktion von CFTR (Cystic fibrosis transmembrane conductance regulator)
Molecular dynamics study of Cl− permeation through cystic fibrosis transmembrane conductance regulator (CFTR)
Codon bias and the folding dynamics of the cystic fibrosis transmembrane conductance regulator